by mfantozzi | Nov 4, 2021 | 2021, Past Events, Scientific
Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based targeted products. Roberto De Luca, Head of Antibody Therapeutics at Philogen, is also giving a...by last | Nov 3, 2021 | 2021, Past Events
Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor site. The product contains two highly synergistic cytokine moieties (interleukin-2 and tumor necrosis...by last | Oct 20, 2021 | 2021, Past Events
Listen to Webcastby last | Oct 5, 2021 | 2021, Past Events
Philogen participates at the BIO-Europe Digital 2021 BIO-Europe (informaconnect.com) – 2021, the international partnering event in the life science and pharma industry, on October 25-28, 2021 Please meet with us in case you are interested in a collaboration or...by last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to participate at the Eleventh Annual Biotech Symposium organised by Goldman Sachs on September 7, 2021. The aim of the Symposium is to provide an opportunity for investors to get a broader perspective of the current opportunity set that...by last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to the Life Sciences Conference organised by KBC on September 7-9, 2021. The Conference provides an opportunity for investors to get a perspective of current opportunities and to meet CEO Dario Neri through a series of one-on-one meetings....